Clinical Trial Update: Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) for severe peripheral artery disease; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Peripheral Vascular Diseases | EARLY_Phase 1 | Status: COMPLETED